These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6175230)

  • 1. Structural requirements for action of cholecystokinin on enzyme secretion from pancreatic acini.
    Villanueva ML; Collins SM; Jensen RT; Gardner JD
    Am J Physiol; 1982 Apr; 242(4):G416-22. PubMed ID: 6175230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas.
    Abdelmoumene S; Gardner JD
    Am J Physiol; 1980 Oct; 239(4):G272-G279. PubMed ID: 6158873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion.
    Villanueva ML; Martinez J; Bodanszky M; Collins SM; Jensen RT; Gardner JD
    Am J Physiol; 1982 Sep; 243(3):G214-7. PubMed ID: 6180646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-induced persistent stimulation of enzyme secretion from pancreatic acini.
    Collins SM; Abdelmoumene S; Jensen RT; Gardner JD
    Am J Physiol; 1981 Jun; 240(6):G459-65. PubMed ID: 6166200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-induced residual stimulation of enzyme secretion from mouse pancreatic acini.
    Younes M; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1987 Oct; 930(3):410-8. PubMed ID: 2443185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP.
    Collins SM; Abdelmoumene S; Jensen RT; Gardner JD
    Am J Physiol; 1981 Jun; 240(6):G466-71. PubMed ID: 6166201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bombesin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas.
    Lee PC; Jensen RT; Gardner JD
    Am J Physiol; 1980 Mar; 238(3):G213-8. PubMed ID: 6154421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of theophylline on secretagogue-stimulated amylase release from dispersed pancreatic acini.
    Korman LY; Walker MD; Gardner JD
    Am J Physiol; 1980 Oct; 239(4):G324-G333. PubMed ID: 6158875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramaximal inhibition of cholecystokinin-induced pancreatic amylase release involves desensitization to cytoplasmic Ca2+.
    Nilsson J; Sjödin L; Gylfe E
    Scand J Gastroenterol; 1994 Jun; 29(6):561-8. PubMed ID: 7521537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues.
    Pandol SJ; Sutliff VE; Jones SW; Charlton CG; O'Donohue TL; Gardner JD; Jensen RT
    Am J Physiol; 1983 Nov; 245(5 Pt 1):G703-10. PubMed ID: 6195929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.
    Lin CW; Bianchi BR; Grant D; Miller T; Danaher EA; Tufano MD; Kopecka H; Nadzan AM
    J Pharmacol Exp Ther; 1986 Mar; 236(3):729-34. PubMed ID: 2419543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbobenzoxy amino acids: structural requirements for cholecystokinin receptor antagonist activity.
    Maton PN; Sutliff VE; Jensen RT; Gardner JD
    Am J Physiol; 1985 Apr; 248(4 Pt 1):G479-84. PubMed ID: 2580448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.
    Bianchi BR; Miller TR; Witte DG; Lin CW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Jensen RT
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of extracellular calcium on amylase release from dispersed pancreatic acini.
    Gardner JD; Costenbader CL; Uhlemann ER
    Am J Physiol; 1979 Jun; 236(6):E754-62. PubMed ID: 443428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of tryptophan-modified analogues of cholecystokinin-octapeptide with cholecystokinin receptors on pancreatic acini.
    Adachi H; Rajh HM; Tesser GI; de Pont JJ; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1981 Dec; 678(3):358-63. PubMed ID: 6172157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin-induced restricted stimulation of pancreatic enzyme secretion.
    Barlas N; Jensen RT; Gardner JD
    Am J Physiol; 1982 May; 242(5):G464-9. PubMed ID: 6177251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.